Arius Formulations Private Limited
About Arius Formulations Private Limited
Data last updated:
Arius Formulations Private Limited is a private limited company based in Auroville Post, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 August 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33110TN2009PTC072482. Its GSTIN is 33AAHCA8759N1Z1 (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Nataraj (Managing Director) and Alamelu Nataraj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Auroville Post, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.26 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹37.81 Lakh (net margin 2%) and EBITDA of ₹87.4 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 13% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Arius Formulations. As per MCA filings, the company has open charges of ₹3.16 Cr and satisfied charges of ₹80 Lakh on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressR.S. No. 141/1 Plot No. 38 & 47 Navarkulam Main Road Pattanur Auroville (Post) Tamil, Nadu, Auroville Post, Tamil Nadu, India – 605101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Arius Formulations Private Limited
The main business activity of Arius Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Arius Formulations Private Limited FY 2025 filings available
Arius Formulations Private Limited reported revenue of ₹19.26 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Arius Formulations Private Limited
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Arius Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹87.4 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹37.81 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Arius Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Arius Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Arius Formulations Private Limited
Arius Formulations Private Limited is compared with the companies closest to it by revenue in the FMCG industry (Formulations, Personal Care and Skin Care). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| G Nine Bioceuticals Private Limited | ₹19.42 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Karnal, Haryana, India |
| Avlaan Pharmaceutical Private Limited | ₹19.36 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Chennai, Tamil Nadu, India |
| Medic Biologicals and Pharmaceuticals Private Limited | ₹19.33 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Thiruvananthapuram, Kerala, India |
| Lxir Medilabs Private Limited | ₹19.32 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Panchkula, Haryana, India |
| Delius Pharmaceuticals Private Limited | ₹19.28 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Arius Formulations Private Limited this company | ₹19.26 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Auroville Post, Tamil Nadu, India |
| Anax Lifescience Private Limited | ₹19.25 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Ahmedabad, Gujarat, India |
| Shriom Organics Private Limited | ₹19.24 Cr (FY 2025) | •••• | •••• | 68.0% | •••• | Paonta, Himachal Pradesh, India |
| Curosis Healthcare Private Limited | ₹19.23 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Ahmedabad, Gujarat, India |
| Elkos Healthcare Private Limited | ₹19.21 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Shahabad Markanda, Haryana, India |
| Dr. Jaikaran LLP | ₹19.21 Cr (FY 2023) | •••• | •••• | 33.0% | •••• | Netaji Subhash Place, Delhi, India |
Peers are the five companies nearest above and the five nearest below Arius Formulations by revenue in the FMCG industry (Formulations, Personal Care and Skin Care), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Arius Formulations Private Limited
Arius Formulations Private Limited is audited by D MUTHUNARAYANAN & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| D MUTHUNARAYANAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Arius Formulations Private Limited
Arius Formulations has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nataraj | Managing Director | 05 Aug 2009 | 17 Years 2 Months | Current |
| Alamelu Nataraj | Director | 05 Aug 2009 | 17 Years 2 Months | Current |
Ownership and Shareholding of Arius Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Arius Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2023 | Others | ₹33.63 Lakh | Open |
| 03 Oct 2022 | Others | ₹1.66 Cr | Open |
| 20 Mar 2017 | Vijaya Bank | ₹70 Lakh | Open |
| 26 Apr 2013 | Vijaya Bank | ₹6.38 Lakh | Open |
| 05 Dec 2009 | Vijaya Bank | ₹40 Lakh | Open |
Total charge records: 7 View all charges
Legal Cases of Arius Formulations Private Limited
Arius Formulations Private Limited has 3 court cases on record: 2 filed by Arius Formulations, 1 filed against it. 1 case is pending and 2 are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Puducherry | Criminal case | Filed by the company against Skin Pharamaceuticals Pvt Ltd | Pending |
| District court, Madurai, Tamil Nadu | Criminal case | Filed against the company by an individual | Disposed |
| District court, Puducherry | Criminal miscellaneous application | Filed by the company | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Arius Formulations Private Limited
Arius Formulations operates one associated brand: Arius Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Third-party manufacturer of pharmaceuticals, cosmetics, and pet care items. | ariusfpl.com |
Employees and EPFO Compliance at Arius Formulations Private Limited
Arius Formulations Private Limited has a workforce of 14 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Arius Formulations Private Limited
Arius Formulations Private Limited has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Valli Kanakasabai ceased to be Additional Director on 24 Sep 2019.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Arius Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Arius Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Arius Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Arius Formulations Private Limited
Arius Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCA8759N1Z1 | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Arius Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arius Formulations Private Limited
Arius Formulations is an active private limited company based in Auroville Post, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 August 2009 (17+ years old) and is registered under CIN U33110TN2009PTC072482.
Arius Formulations reported revenue of ₹19.26 Cr for FY 2025 (down 12% YoY).
Arius Formulations has 2 current directors:
- Nataraj - Managing Director
- Alamelu Nataraj - Director
Arius Formulations reported a net profit of ₹37.81 Lakh (net margin 2%) and EBITDA of ₹87.4 Lakh (EBITDA margin 4.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Arius Formulations is 14% over three years and 13% over five years. In the latest year (FY 2025) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Arius Formulations is 33AAHCA8759N1Z1, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Arius Formulations is U33110TN2009PTC072482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arius Formulations has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending.
Arius Formulations was incorporated on 05 August 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Arius Formulations by revenue are G Nine Bioceuticals Private Limited, Avlaan Pharmaceutical Private Limited, Medic Biologicals and Pharmaceuticals Private Limited, Lxir Medilabs Private Limited, Delius Pharmaceuticals Private Limited and 5 more, all in the FMCG industry (Formulations, Personal Care and Skin Care).
Valli Kanakasabai ceased to be Additional Director on 24 Sep 2019. Balasubramanian Anandapadmanaban ceased to be Director on 11 Feb 2010. Suresh Thottakat Shankaran ceased to be Director on 11 Feb 2010. Arius Formulations has 6 board changes on record in total.